Palvella Therapeutics Q3 2026 Earnings Call Transcript
Palvella Therapeutics recently attended the FDA’s public meeting on the initiative held on October 28th in partnership with the Reagan-Udall Foundation.
- About
-
Projects
-
Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
-
Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
-
Column 1
- News and Events
- Expanded Access eRequest